Le Lézard
Classified in: Business
Subjects: CALENDAR OF EVENTS, STOCK/OTHER MARKET NEWS

European Metals Holdings Limited to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on November 8th, 2023


PERTH, Australia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- European Metals Holding Limited (ASX & LON: EMH, OTCQX: ERPNF, ADS:EMHXY) based in Perth, and focused on the development of the Cinovec Lithium Project in the Czech Republic, today announced that Keith Coughlan, Executive Chairman will present at the dbVIC - Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference on November 8th, 2023. This virtual investor conference is aimed exclusively at introducing global companies with ADR programs to investors.

DATE: November 8th, 2023
TIME: 8.30 am ET
LINK: https://bit.ly/3wffkNB

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Participation is free of charge.

Recent Company Highlights

About European Metals Holdings Limited

European Metals is developing the Cinovec Project ? the largest hard rock lithium resource in Europe, located in the Czech Republic. The project is fully funded to Final Investment Decision, expected Q4 2023 and is actively supported by both the Czech Government and the European Union. Cinovec will be a fully integrated lithium project producing approximately 29,386 tpa of battery grade lithium hydroxide and/or lithium carbonate for the rapidly growing European Battery industry and Electric Vehicle industry. The Cinovec Project has the potential to have one of the lowest overall environmental impacts compared to other conventional lithium battery metals projects not only in Europe but also on a global basis.

About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.



These press releases may also interest you

at 08:30
Sila Realty Trust, Inc. today announced operating results for the first quarter ended March 31, 2024. All per share data has been retroactively adjusted to reflect the one-for-four reverse stock split which occurred on May 1, 2024. Highlights of...

at 08:29
The following issues have been halted by CIRO: Company: Nabati Foods Global Inc. CSE Symbol: MEAL  All Issues: Yes Reason: Cease Trade Order Halt Time (ET): 7:45 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a...

at 08:29
The following issues have been halted by CIRO Company: NexOptic Technology Corp TSX-Venture Symbol: NXO All Issues: Yes Reason: Cease Trade Order Halt Time (ET): 7:45 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in...

at 08:27
Lucid Bots Inc., an industry leader in cutting-edge robotics for labor-intensive tasks, announced today that it has raised $9.1M in Series A funding led by Cubit...

at 08:26
Klear.ai, a leader in risk, claims, and analytics solutions, proudly announces its continued high ranking in the 2024 RMIS Report ? for the second year in a row! Highlighting their continued innovation and leadership in the sector through significant...

at 08:25
Anixa Biosciences, Inc. ("Anixa" or the "Company") , a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that it has entered into a joint development agreement with Cleveland Clinic to develop...



News published on and distributed by: